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TheDNAdamageresponse(DDR)cascadeandROS(reactiveoxygenspecies)signalingarebothinvolvedintheinductionofcell
death after DNA damage, but a mechanistic link between these two pathways has not been clearly elucidated. This study
demonstrates that ROS induction after treatment of cells with neocarzinostatin (NCS), an ionizing radiation mimetic, is at least
partly mediated by increasing histone H2AX. Increased levels of ROS and cell death induced by H2AX overexpression alone or
DNA damage leading to H2AX accumulation are reduced by treating cells with the antioxidant N-Acetyl-L-Cysteine (NAC), the
NADP(H) oxidase (Nox) inhibitor DPI, expression of Rac1N17, and knockdown of Nox1, but not Nox4, indicating that induction of
ROS by H2AX is mediated through Nox1 and Rac1 GTPase. H2AX increases Nox1 activity partly by reducing the interaction
between a Nox1 activator NOXA1 and its inhibitor 14-3-3zeta. These results point to a novel role of histone H2AX that regulates
Nox1-mediated ROS generation after DNA damage.
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DNA double-strand breaks (DSBs) can cause genetic muta-
tions that activate oncogenes, inactivate tumor suppressors,
andchangethe levelsorfunctionsof‘modiﬁer’proteins, which
determine chemosensitivity or tumor progression, thus
potentially increasing an organism’s susceptibility to cancer
and a myriad of other diseases.
1,2 To defend themselves
against the deleterious effects of DSBs, eukaryotic organisms
employ an intricate DNA damage response (DDR) pathway to
detectDNAlesions,arrestthecell cycle untildamagedDNAis
repaired, and to induce cell death if the lesions are over-
whelmed.
1–3 Thus, efﬁcient induction of the DDR and cell
death pathways after DNA damage is crucial in cellular
defenses against malignant transformation.
One of the most important proteins in the DDR pathway is
histoneH2AX.
4,5 Resultsfrom H2AXknockout studiesinmice
indicate that loss of one or two copies of the H2AX gene
compromises genomic integrity and DDR efﬁciency and
increases tumor formation in a p53-null background.
6
Furthermore, H2AX phosphorylation status has been shown
todeterminewhethercellsrepairthedamagedDNAtosurvive
or undergo apoptosis.
7 In response to DNA DSBs, ATM and/
or DNA-PK phosphorylate histone H2AX at Ser139 to form
gH2AX.
8 Formation of gH2AX foci on DSB sites is the earliest
and the critical event in the DDR pathway.
4,5,9–11 H2AX not
onlyservestoindicatethelocalizationofDNAlesions,
10butits
phosphorylation and subsequent ubiquitylation by the RNF8
ubiquitin ligase are required for DNA damage signal ampliﬁ-
cation and the accumulation of numerous DDR proteins at the
sites of DSBs to form the so-called ionizing radiation-induced
foci.
4,5,9,12
Another important determinant of genomic integrity and
cellular response to DNA damage is the level of intracellular
reactive oxygen species (ROS), which is tightly regulated
through the coordinated activities of cellular pro-oxidants and
antioxidants. IntracellularROScanactasacellulartoxicantor
a signaling molecule, depending on its concentration and
localization. Intracellular ROS is primarily generated through
aerobic metabolism or through a specialized group of
enzymes, collectively known as the NAD(P)H oxidases
(Noxes). Human cells possess seven distinct Nox enzymes
including: Nox1-5 and Duox1-2 (reviewed in
13–15). Among
them is Nox1 that is expressed in epithelial cells and non-
phagocytes. At the molecular level, Nox1 associates with the
membrane subunit p22
phox, which is necessary for enzymatic
activity.
16 Nox1 is activated by forming a complex with the
cytoplasmic activators p47
phox and p67
phox (and their non-
phagocytic homologs NoxO1 and NoxA1)
17 and the small
GTPase Rac1.
13,18 The primary ROS produced by Nox1 is
O2. , although H2O2 is thought to be the most important
signaling molecule in Nox1 signal transduction. Importantly,
Nox1-induced ROS has been implicated in oncogenic signal-
inginRas-transformedNIH3T3cells,wheredepletionofH2O2
suppressed uncontrolled cell growth.
19
DNA damage from various sources has been shown to
increase ROS levels.
20 DNA damage-induced ROS is
important in the regulation of cell death and survival,
21,22
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23,24 In turn, the
tumor suppressor p53 has been demonstrated to regulate
basal and DNA-damage-induced ROS levels.
24–26 However,
the exact mechanism by which DNA damage induces ROS
and the involvement of other DDR proteins in ROS generation
remain to be elucidated.
In this study, we demonstrate that DNA damage induces
ROS through histone H2AX, Nox1, and Rac1. DNA damage-
induced ROS is signiﬁcantly increased by H2AX overexpres-
sion and reduced by its knockdown. ROS induction by histone
H2AX expression can be abrogated by treatment of cells with
the Nox inhibitor diphenyliodonium chloride (DPI), expression
of a dominant negative Rac1 mutant (Rac1N17), and knock-
down of Nox1. Recent studies have demonstrated that 14-3-
3zeta binds to NoxA1, resulting in the inactivation of Nox1 by
sequestration of NOXA1 from Nox1 in the plasma mem-
brane.
27 More recent proteomic analysis indicated that H2AX
constitutively binds to 14-3-3zeta in a normally growing
human hepatocellular carcinoma cell line.
28 We found that
14-3-3zeta forms a complex with NOXA1 in control U2OS
cells, and that H2AX overexpression reduces this interaction.
We also found that DNA damage generates an oscillation of
increased ROS, and that suppression of DNA damage-
induced ROS by the antioxidant N-Acetyl-L-Cysteine (NAC)
reduces apoptosis. Our results point to a novel interaction
between H2AX and Nox1, which regulates ROS levels and
apoptosis after DNA damage.
Results
ROS induction after DNA damage in mammalian
cells. DNA damage has been shown to stimulate the
production of ROS in cell cultures.
20,29,30 We ﬁrst examined
how different DNA-damaging agents induce ROS in different
mammalian cell lines. Sub-conﬂuent U2OS (human
osteosarcoma) and HBL100 (human mammary epithelial)
cells were seeded onto 96-well plates, treated with
neocarzinostatin (NCS, a radiomimetic reagent),
doxorubicin, or hydroxyurea (HU) for 20min to 5h, and
ROS levels were quantiﬁed using the ﬂuorogenic dye DCFH-
DA and a ﬂuorescence microplate reader.
31 Although there
were some differences in the amplitudes and kinetics of ROS
induced by NCS, doxorubicin, and HU, all three compounds
induce ROS biphasically in this time course, with an early
ROS burst occurring within 2h of DNA damage, a transient
drop within 2–3.5h, followed by a second ROS burst
occurring within 3.5–5h of DNA damage (Figure 1a).
ROS induces cell death after DNA damage. We tested if
DNA-damage-induced ROS is important for the induction of
Figure 1 Exposure to DNA-damaging agents leads to increased levels of ROS that contribute to cell death. (a) Sub-conﬂuent U2OS and HBL100 cells were treated with
the DNA-damaging agents neocarzinostatin (NCS, 0.5mg/ml), hydroxyurea (HU, 2mM), and doxorubicin (8.5mM) for 20min to 5h. ROS levels were quantiﬁed using DCFH-
DA anda ﬂuorescentmicroplatereader. (b) Addition of 6 or 30mM NAC 2h afterNCS treatment suppressed thelatent NCS-inducedincrease in ROS. (c) Suppressionof the
latent NCS-induced ROS by NAC treatment reduced NCS-induced apoptosis
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Cell Death and Diseaseapoptosis. To study this, we suppressed the second NCS-
induced ROS burst by adding the antioxidant NAC 2h after
NCS treatment, and quantiﬁed total cell death 24h later. NCS
induces DNA damage through the generation of free
radicals,
32,33 resulting in the activation of DDR
components, such as ATM, H2AX, p53, and DNA-PK. As
expected, adding NAC immediately after NCS addition
prevented both ROS production and the DNA-damage-
induced activation of DDR proteins (data not shown).
Meanwhile, adding NAC 2h after NCS treatment abrogated
the second burst of NCS-induced ROS without interfering
with DDR activation (Figure 1b), allowing us to more
accurately determine the effect of NCS-induced ROS on
apoptosis induction. We found that suppression of the
second NCS-induced ROS burst by NAC treatment
signiﬁcantly reduces cell death (Figure 1c). These results
indicate that, once DDR proteins are activated immediately
after DNA damage, an oscillation of increased ROS is
generated, and this is crucial for subsequent cell death. Of
note, the second burst of ROS induction is much higher than
the ﬁrst when cells are treated with NCS (Figure 1a),
although phosphorylation of H2AX and ATM at Ser1981
are signiﬁcantly lower than those observed within 20min
after treatment (Figure 2).
DNA damage increases levels of protein and
phosphorylation of histone H2AX. It has been well
illustrated that histone H2AX is involved in DNA stress
pathways and is phosphorylated by ATM in response to cell
stress, and that the phosphorylated form of H2AX (gH2AX)
colocalizes to sites of DNA lesions.
4,11,34 We found that,
when the U2OS human osteosarcoma cell line and the
HBL100 human mammary epithelial cell line are treated with
NCS, levels of histone H2AX protein are markedly increased
within 20–45min after treatment (nearly 2–3-fold in U2OS
and HBL100 cells, respectively; Figure 2 and Supplementary
Figure 1). An increase in H2AX protein levels was also
observed when cells were treated with doxorubicin (data not
shown). When gH2AX levels were normalized to H2AX
protein levels through densitometric analysis, we found that
NCS treatment did not increase H2AX phosphorylation in
U2OS or HBL100 cells (Supplementary Figure 1). Of note,
upregulation of H2AX after NCS treatment preceded that of
ROS (Figures 1 and 2), raising the possibility that H2AX may
mediate ROS induction after DNA damage.
Histone H2AX mediates ROS induction after DNA
damage. By using U2OS and HBL100 cell lines, we
established stable cell lines either overexpressing Flag-
tagged H2AX (Flag-H2AX), or expressing a tet-regulatable
H2AX shRNA in which the level of endogenous H2AX is
decreased in the presence of doxycycline in cell culture.
Using these cell lines, we tested whether levels of H2AX
determine the basal or NCS-induced levels of ROS. Levels of
Flag-H2AX and decreased levels of endogenous H2AX by
shRNA were conﬁrmed by immunoblot analysis. We found
that, when H2AX was highly expressed in U2OS and
HBL100 cells, basal levels of ROS were signiﬁcantly
increased, and that ROS was further produced when cells
were treated with NCS, when compared with the levels of
ROS in control U2OS and HBL100 cells (Figures 3a and b).
Next, we knocked down endogenous histone H2AX by
treating cells expressing tet-regulatable H2AX shRNA with
doxycycline. Although basal levels of ROS did not change
when endogenous H2AX was knocked down, induction of
ROS by NCS was signiﬁcantly attenuated (Figures 3c and d).
Together, the results from our H2AX overexpression and
knockdown experiments provide strong evidence that H2AX
can regulate ROS levels.
Histone H2AX upregulates DNA-damage-induced ROS
through Nox1 and Rac1. We investigated the mechanism
by which histone H2AX increased the levels of ROS after
DNA damage. Several proteins and pathways have been
implicated in ROS production in mammalian cells. Among
them are the NADP(H) oxidase (Nox) family of proteins:
membrane-associated, multimeric ﬂavin-containing enzymes
that catalyze the reduction of oxygen using electrons from
NADPH. A number of regulatory subunits have been
identiﬁed for the Nox proteins, including p22
phox, NoxO1,
NoxA1, and Rac1.
13–15,17,35,36 When parental U2OS cells
were treated with NCS for 5h, levels of ROS increased about
1.5-fold, whereas U2OS cells expressing Flag-H2AX
exhibited higher induction of ROS compared with untreated
U2OS cells expressing Flag-H2AX (B1.8-fold, Figure 4a).
However, when parental and Flag-H2AX expressing U2OS
cells were treated with NCS in the presence of 0.5mM
diphenyliodonium chloride (DPI, a broad-spectrum inhibitor
of ﬂavin-containing enzymes including Noxes), the increase
in ROS was almost completely inhibited.
Inhibition of NCS-induced increases in ROS by DPI was
also observed in HBL100 cells (Figure 4b). Levels of ROS in
control HBL100 cells were increased B3.5-fold with NCS
treatment. When Flag-H2AX was expressed in HBL100 cells,
induction of ROS was further increased B4.3-fold compared
Figure 2 Upregulation and phosphorylation of H2AX is an early event in the
DDR cascade. U2OS and HBL100 cells were treated with NCS (0.5mg/ml), for
20min to 5h in PBS buffer (to mimic the condition of cells used for ROS assays).
LevelsandphosphorylationofH2AXandATMproteinwereassayedbyimmunoblot
analysis using antibodies indicated
H2AX regulation of ROS production
MA Kang et al
3
Cell Death and DiseaseFigure 3 Histone H2AX increases basal and DNA damage-induced ROS. Overexpression of Flag-H2AX increased basal and NCS-induced ROS in U2OS (a) and
HBL-100 (b) cells, whereas inducible H2AX knockdown reduces NCS-induced ROS in HCT-116 (c) and HBL100 (d) cells. Immunoblot analysis was performed at 5h after
NCS treatment. **Flag-tagged H2AX, *endogenous H2AX
Figure 4 H2AXincreases ROSthroughNox1/Rac1pathway.Control U2OS cells(a,white bar),Flag-H2AXU2OScells (a, black bar),controlHBL100 cells(b, white bar),
and Flag-H2AX HBL100 cells (b, black bar) were treated with NCS (0.5mg/ml, 5h) with or without the Nox-inhibitor, DPI (0.5mM) and fold-induction of ROS was measured.
(c) Vector control cells or Flag-H2AX U2OS cells were transiently transfected with an indicated plasmid with a control vector for 12h, followed by NCS treatment (0.5mg/ml)
for 5h. Levels of ROS were measured in more than three independent experiments. (d) Levels of proteins were immunoblotted to conﬁrm expression or knockdown of
indicated proteins. (e) Expression of H2AX inhibited coimmunoprecipitation of 14-3-3zeta with NOXA1. U2OS cells were transfected with the indicated plasmids, followed
by GST-pulldown of 14-3-3zeta. **Flag-taged H2AX, *endogenous H2AX
H2AX regulation of ROS production
MA Kang et al
4
Cell Death and Diseasewith untreated HBL100 cells expressing Flag-H2AX
(Figure 4b). Two different concentrations of DPI (0.2 and
0.5mM) were examined; both concentrations inhibited ROS
production in control HBL100 cells and HBL100 cells
expressing Flag-H2AX. Of note, DPI did not completely inhibit
ROS production in these cell lines at these concentrations,
which suggests that Nox-independent mechanisms also
produce ROS in HBL100 cells.
These results strongly suggest that H2AX induces ROS by
activating Nox protein(s) when cells are exposed to DNA-
damaging agents. We then sought to identify the Nox enzyme
that mediates H2AX-induced ROS. Nox1 and Nox4 are the
twomostubiquitousNoxenzymesinepithelialandendothelial
cells,
34 whereas Nox2 is highly expressed in phagocytes.
37
It has been demonstrated that Nox1 activity is Rac1-depen-
dent,
13,18 whereas Nox4 activity is not.
37,38 Based on these
observations, we used the pSilencer4.1-CMV-neo vector to
generate a plasmid expressing Nox1 shRNA and examined
the effect of Nox1 knockdown on DNA-damage-induced ROS
in H2AX overexpressing cells. In vector control U2OS cells,
NCS treatment increased ROSB1.7-fold. Basal levels of
ROS in U2OS cells expressing Flag-H2AX were higher
(B2.0-fold) than U2OS vector control cells; this was further
increased B4.4-fold when cells were treated with NCS. We
found that Nox1 knockdown with shRNA similarly reduced
both basal and DNA-damage-induced ROS in U2OS cells
expressing Flag-H2AX to B1.5-fold (Figure 4c). Of note, this
is still higher than control, suggesting that DNA damage also
induces ROS through pathways that do not involve the H2AX-
Nox1 axis (see Figure 5). Consistent with these observations,
when Nox1 is knocked down in NCS-treated parental U2OS
and 293T cells, ROS were still produced (Supplementary
Figure 4). On the other hand, when Nox4 is knocked down in
U2OS cells expressing Flag-H2AX, no signiﬁcant decrease in
the levels of basal and NCS-induced ROS was observed
(Figure 4c).
To further investigate whether the Nox1 pathway was
involved in H2AX-mediated ROS induction, we introduced a
dominant negative form of Rac1 (Rac1N17) in parental and
Flag-H2AX-overexpressing U2OS cells to inhibit the Rac1
GTPase, which is necessary for the activation of Nox1.
13
When Rac1N17 was co-expressed in Flag-H2AX U2OS cells,
basal and NCS-induced levels of ROS were decreased to
B1.5-fold and B2.6-fold, respectively, compared with the
untreated Flag-H2AX U2OS cells (Figure 4c). Knockdown of
Nox1 also reduced basal levels of ROS in those cells
(Supplementary Figure 2). Levels of the proteins studied in
these experiments were shown in Figure 4d.
We then explored the mechanisms of how increased H2AX
increases the levels of ROS. Recent studies have demon-
strated that 14-3-3zeta binds to NoxA1, resulting in the
inactivation of Nox1 by sequestration of NoxA1 from Nox1 in
theplasmamembrane.
27Interestingly,morerecentproteomic
analysis indicated that H2AX constitutively binds to 14-3-
3zeta in a normally growing human hepatocellular carcinoma
cell line.
28 It is therefore possible that DNA damage-induced
H2AX titrates out the 14-3-3zeta from NoxA1, thus potentially
increasing the formation of an active Nox1/NoxA1 complex.
We found that GST-tagged 14-3-3zeta co-immunoprecipi-
tatesacomplexcontainingHA-taggedNoxA1incontrolU2OS
cells. However, this complex was not detected in Flag-H2AX
U2OS cells (Figure 4e). Thus, we postulate that overexpres-
sion of H2AX causes NoxA1 to be released from 14-3-3zeta
resulting in an increase in ROS levels.
It has been illustrated that EGF stimulation or oncogenic
signals such as K-RasVal12 upregulates Nox1 mRNA.
19 In
light ofthis,we testedwhetherthe activation ofNox1 signaling
by H2AX occurs through an upregulation in Nox1 protein
levels. However, we found that neither H2AX overexpression
nor H2AX depletion by shRNA causes a signiﬁcant change in
Nox1proteinlevels(notshown),suggestingthattheactivation
of Nox1 pathway by H2AX is not through an increase in the
levels of Nox1 protein.
These results indicate that the increased level of H2AX in
DNA-damaged cells promotes the activation of the Nox1/
Rac1 pathway and ultimately increases intracellular levels of
ROS.
H2AX-mediated apoptosis is inhibited by Rac1N17. It
has been shown that high levels of ROS can induce
apoptosis.
22 As our results demonstrate that expression of
H2AX increases the levels of ROS, we tested whether H2AX
can induce apoptosis without DNA stress. Constitutive levels
of apoptosis were determined in control and Flag-H2AX
U2OS cells. As shown in Figure 6a, levels of apoptosis are
Figure 5 Model of ROS induction by H2AX after DNA damage. DNA damage
induces levels and phosphorylation of H2AX. Then, H2AX activates Rac1 GTPase
and Nox1 by sequestering 14-3-3zeta, leading to increase in intracellular levels of
ROS. H2AX can also induce ROS and apoptosis by the alternative pathways that
are usually inhibited by Nox1
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H2AX. Increased levels of apoptosis were also studied in
293T and U2OS cells transiently co-expressing Flag-H2AX
and HA-Rac1N17 (Figures 6b and c). In both cell types,
expression of Flag-H2AX signiﬁcantly increased the level of
apoptosis, whereas co-expression of HA-Rac1N17 reduced
Flag-H2AX-induced apoptosis. Inhibition of apoptosis by
HA-Rac1N17 was less effective in 293T cells than in U2OS
cells, suggesting that regulation of apoptosis by H2AX/Rac1
may be determined by cell context.
Discussion
DNA damage from various sources has been shown
to increase intracellular levels of ROS,
20 which in turn
regulates cell death or senescence through p53-dependent
and -independent mechanisms.
22 Induction of cell death or
senescence is one of the most important defense responses
against malignant transformation. A well-characterized path-
way of ROS production and regulation is through the p53
tumor suppressor and the mitochondria.
21,24 However, the
detailed mechanism of ROS generation after DNA damage
remains to be uncovered and the roles of other DDR proteins
in ROS regulation still need to be investigated.
OurstudiesindicatethatDNAdamage-inducedapoptosisis
reduced when the second burst of DNA damage-induced
ROS is suppressed by treatment of cells with the antioxidant
NAC. Autophosphorylation of ATM at Ser1981 occurred
within 20min of NCS treatment. On the other hand, an
increase in H2AX protein and its phosphorylation was initially
observed within 20min after NCS treatment and reached its
peak within 45min in U2OS and HBL100 cell lines. We found
Figure 6 High levels of H2AX induces apoptosis without DNA damage, which is decreased by Rac1N17. (a) U2OS cells stably expressing Flag-H2AX show constitutive
apoptosiswithoutDNAdamage,comparedwithvecetorcontrolcells.293T(b)orU2OS(c)cellsweretransfectedwithexpressionvectorsofFalg-H2AX,HA-Rac1N17orboth
for 48h, and apoptosis was compared with that of vector control cells. A bar graph represents fraction of apoptotic cells
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U2OS and HBL100 cells, Figure 1a) was not accompanied by
increased phosphorylation of ATM and H2AX (Figure 2, data
not shown), indicating that the ﬁrst burst, but not the second,
of ROS induction within the ﬁrst 20–45min after DNA damage
require the activation/phosphorylation of DDR proteins and
the resultant apoptotic phenotype.
Although the importance of histone H2AX in the accumula-
tion of DDR and repair proteins at sites of DSBs has been well
established,
4,5,9,12 the role of H2AX in other signaling path-
ways is not fully understood. In this study, we established a
novel pathway that DNA damage increases intracellular ROS
levels through histone H2AX, Rac1, and Nox1. We found that
levels of intracellular ROS are increased by not only DNA
damage but also H2AX overexpression. Given that DNA
damage increases endogenous levels of ROS,
24–26 our
results suggest a signaling loop between ROS production
and increase in H2AX to amplify the signal causing apoptosis.
In the cell lines we tested, DNA damage induces ROS
biphasically, with an early burst occurring within 45min of
DNA damage induction and a late second burst occurring
within 5h. The late burst of ROS induced by NCS can be
inhibited by either Nox1 shRNA or Rac1N17 (see Supple-
mentary Figure 3). However, the early burst of ROS is not
inhibited by Nox1 shRNA or Rac1N17, suggesting that
whereas the late burst of ROS is generated through the
Nox1/Rac1 axis, the early burst is induced through DDR
components.Furthermore, whenRac1/Nox1 isinhibited, cells
still produce certainlevels ofROS (Figure 4c), suggesting that
production of ROS is at least in part ampliﬁed in Rac1/Nox1-
independent manner.
We found that overexpression or knockdown of H2AX does
not signiﬁcantly change Nox1 protein levels (Figure 4, not
shown), suggesting that H2AX does not increase ROS levels
by augmenting Nox1 protein expression or stability. However,
coimmunoprecipitation assays indicate that the Nox1 activa-
tor NoxA1 is released from 14-3-3zeta in cells expressing
high levels of H2AX. As it has been shown that binding of
14-3-3zeta to NoxA1 complex is inhibitory for Nox1 activity,
27
we propose a model where increased H2AX binds and
sequester cellular 14-3-3zeta, resulting in the release of
NoxA1 and the activation of Nox1 complex.
There are some potential links between our ﬁndings and
human diseases. Constitutive production of superoxide was
induced upon Ras transformation in NIH3T3 cells, and
depletion of its dismutated metabolite H2O2 suppressed the
uncontrolled growth of Ras-transformed cells.
39 Signiﬁcantly,
introduction of Nox1 siRNA into K-RasVal12-transformed NRK
(normal rat kidney) cells was shown to block their anchorage-
independent growth and induced morphological reversion,
19
supportingtheideathatNox1-mediatedproductionofROShas
crucial roles in cell transformation. Our observation that H2AX
can activate Nox1/Rac1-mediated production of ROS raises
thepossibilitythat H2AX may be involvedin cell transformation
induced by Ras and other oncogenes.
It has been shown recently that the status of H2AX
phosphorylation is crucial to determine whether cells will survive
or undergo apoptosis after DNA damage.
7 Because ROS can
also activate both cell survival and apoptotic pathways depend-
ing on its concentration and localization,
14,21,37 regulation of
ROSbyH2AXmaybeonemechanismtodeterminecellsurvival
or apoptosis after DNA insults. Therefore, elucidating the
relationship between H2AX phosphorylation status, ROS
regulation, and cell fate after DNA damage may provide
understanding of DDR regulation relevant to the inhibition of
cancer growth and progression.
Materials and Methods
Cell culture. U2OS, HBL100, HeLa, and HCT-116 cells were maintained in
Dulbecco’s Modiﬁed Eagle Medium (GIBCO, Grand Island, NY, USA),
supplemented with 10% fetal bovine serum (Invitrogen, Grand Island, NY, USA)
or cosmic calf serum (HyClone, Logan, UT, USA). To induce DNA damage, cells
were treated with 0.5–1mg/ml neocarzinostatin (Kayaku, Tokyo, Japan), 8.5mM
doxorubicin (Sigma, St. Louis, MO, USA), or 2mM hydroxyurea (Sigma).
Plasmidsand transfection. pSingle-tTs-shRNA vector (Clontech,Mountain
View, CA, USA) was used to generate plasmids expressing tet-inducible H2AX
shRNA with the target sequence 50-CTGGAATTCTGCAGCTAAC-30 or
50-CAACAAGAAGACGCGAATC-30, according to the manufacturer’s instructions.
Brieﬂy, shRNA-encoding oligonucleotides were synthesized, annealed, and cloned
into Xho1/HindIII sites of the vector. pcDNA3-Flag-H2AX was generated by
subcloning Flag-H2AX from pEF into the EcoR1/Not1 sites of pcDNA3. pEF-HA-
Rac1WT/Rac1N17 was generated by PCR ampliﬁcation from a complementary
DNA library, followed by site-directed mutagenesis (Stratagene, Wilmington, DE,
USA) and subsequent subcloning into a pEF vector. pEBG-14-3-3zeta was
purchased from Addgene (Cambridge, MA, USA). Nox1 complementarty DNA in
pcDNA3 was obtained from Drs. Banﬁ Botond (University of Iowa) and Hideki
Sumimoto (Kyushu University, Japan). pSilencer4.1-CMV-Neo vector was used to
generate plasmids expressing Nox1 and Nox4 shRNA with the target sequences
50-CGACAGTGGAGTATGTGAC-30(Nox1) and 50-TTATTGCATATGTAGAGGCTC
TGAT-30 (Nox4), according to the manufacturer’s instructions. Brieﬂy, shRNA-
encoding oligonucleotides were synthesized, annealed, and cloned into HindIII/
BamH1sitesofthevector.TransfectionswereperformedwithFugene-6orFugene-
HD (Roche Applied Science, Indianapolis, IN, USA), according the manufacturer’s
protocol.
Generation of stable cell lines. To generate stable H2AX-overexpression
and tet-on-H2AX-knockdown cell lines, cells were ﬁrst transfected with pcDNA3-
Flag-H2AX and pSingle-tTS-H2AX-shRNA. Forty-eight to seventy-two hours after
transfection, cells were reseeded at low density and stable transfectants were
positively selected using neomycin at pre-optimized concentrations (1000mg/ml for
U2OS, 500mg/ml for HCT116, and 1500mg/ml for HBL100). Stable transfectants
were cultured in neomycin-containing media until colonies become visible (after
approximately 1–2 weeks in culture); media (and neomycin) is changed and
refreshedevery72h.Coloniesweretrypsinizedandtransferredto96-wellor48-well
plates when they become visible, and both colonies and ‘pools’ of stable
transfectants (a pool of the colonies that were not picked) were cultured for an
additional 1–2 weeks. Stable transfectants were subsequently screened for H2AX
overexpression and knockdown through western blot. Inducible H2AX knockdown
was performed by culturing cells stably expressing pSingle-tTS-H2AX-shRNA in
media containing 2mg/ml doxycycline (Sigma) for 24h (HCT116) or 48h (HBL100).
Immunoblot analysis and densitometry analysis. The following
primary antibodies were purchased for immunoblot analysis: for H2AX protein
(77635, Genetex, Irvine, CA, USA), a-tubulin (5286, Santa Cruz Biotechnology,
Santa Cruz, CA, USA), b-actin (C-11, Santa Cruz Biotechnology), HA-probe (Y-11,
Santa Cruz Biotechnology). Nox1 antibody (Abcam, Cambridge, MA, USA) was a
generous gift from Dr. Andrean Simons. Cell extracts were prepared in EBC buffer
(50mM HEPES, pH 7.6, 250mM NaCl, 0.1% Nonidet P-40, 5mM EDTA, pH 8.0,
with mixed protease inhibitor (aprotinin, leupeptin, PMSF; Sigma). The secondary
antibodies (Jackson Immuno-laboratory, Mill Valley, CA, USA) were peroxidase-
conjugated anti-mouse IgG (HþL), anti-rabbit IgG (HþL), or anti-goat IgG
(HþL). Film (Hyblot, Denville Scientiﬁc, Metuchen, NJ, USA) was developed using
ECL (Enhanced ChemiLuminescence) reagent. The level of phosphorylation and
expression of proteins were measured by densitometry using ImageJ software
(NationalInstitutesofHealth)andthedatawereexpressedasarbitraryunitsrelative
to band intensity of total protein or internal control.
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dichlorodihydroﬂuorescein diacetate oxidation (DCFH-DA, Sigma) and a
ﬂuorescence microplate reader.
31 Brieﬂy, cells were seeded onto 96-well plates
(black/clear bottom, BD Biosciences, San Jose, CA, USA) at a density of 5000–
10000 cells per well. Twenty-four hours after seeding (at 40–70% density), cells
werewashedwithPBSbuffer(Invitrogen),treatedwith100mMDCFH-DA(dilutedin
DMEMþ1% FBS) for 1h (at 371C, 5% CO2). Cells were then washed with PBS
again,andtreatedwiththeDNA-damagingagentsNCS,doxorubicin,orhydoryurea
(diluted in PBS) for 20min–5h. DCF ﬂuorescence is measured using a ﬂuorescent
microplate reader (Spectramax, Sunnyvale, CA, USA). Readings were done in
triplicates, quadruplicates, or quintuplicate. ROS levels were normalized to cell
number, which was measured using a ﬂuorogenic DNA-binding dye (CyQuant
Proliferation assay kit, Molecular Probes (Eugene, OR, USA), Invitrogen), and ROS
per cell levels were quantiﬁed by dividing DCF ﬂuorescence with CyQuant
ﬂuorescence. Because DCFH-DA and CyQuant have the same excitation/emission
spectra, we stained cells with DCFH-DA and CyQuant in different (exact replicate)
wells. Error bars represent the average standard error of all the samples in a single
experiment.
Cell death assays. Apoptosis was quantiﬁed using the Annexin V-FITC
ApoptosisDetectionKit(Calbiochem,SanDiego,CA,USA)andaFACScaliburﬂow
cytometer (BD Biosciences), according to the manufacturer’s instructions. Twenty-
four hours after seeding, NCS was added to cell culture media. NAC (Sigma) was
added 2h after NCS addition, and Annexin-V-FITC assays were performed
24h later. Apoptosis of 293T and U2OS cells after transient transfection of
Flag-H2AX/pcDNA3 or HA-Rac1N17/pEF was determined at 48h.
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